The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lafrance Norman D. since 2007.
The trader's CIK number is 1397768.
At the time of the last reporting, Lafrance Norman D. was the Sr. VP Clinical Dev of Molecular Insight Pharmaceuticals, Inc.. (stock ticker symbol MIPI).
Also see all insider trading activities at Molecular Insight Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | MIPI | 0 | $0 | 6,093 | $22,909 | 0 | $0 |
| 2007 | MIPI | 4,000 | $33,530 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-05-28 | MIPI | Sale | 6,093 | 3.76 | 22,909 |
| 2007-11-30 | MIPI | Buy | 2,000 | 8.77 | 17,530 |
| 2007-11-29 | MIPI | Buy | 2,000 | 8.00 | 16,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lafrance Norman D. (Sr. VP Clinical Dev of Molecular Insight Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.